Heritage Cannabis Reveals Purefarma and Pura Vida Products are now Offered Online on the EndoDNA Website myDNA.live

TORONTO–( ORGANIZATION WIRE)– Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (” Heritage” or the “Business”), today revealed that its Purefarma and Pura Vida items are now readily available on the EndoDNA website myDNA.live

The EndoDNA test introduced in Canada in late 2019 through Heritage’s partially owned subsidiary Endocanna Health Inc. (” Endocanna”). The test, which is readily available on endodna.com, evaluates over 500 genes and more than 550,000 Single Nucleotide Polymorphisms in the body, and supplies an individualized Endo · Translated report through a protected website, recognizing how a person’s particular hereditary makeup engages with cannabinoids and terpenes.

The EndoDNA test guides people based upon these outcomes, and supplies genetically lined up item suggestions, now consisting of Purefarma and Pura Vida items, that will use people a more ideal experience withcannabis

” Having our items readily available through myDNA.live is another channel for customers to access our award winning items, and to supply people with the tools and resources to make positive choices when including cannabis into their lives,” specified Clint Sharples, CEO of Heritage. “We continue to broaden our item offerings throughout Canada’s provincial boards, and online platforms in and effort to make the most of customer access to our in-demand items.”.

” EndoDNA is really an individualized experience when it pertains to picking cannabis items with the best cannabinoid profile and helps with selecting formula, dose, and finest shipment approach for customers requirements,” commented Len May, Endocanna Health co-founder and CEO. “Discovering the best item for particular requirements can be tough and now with Purefarma and Pura Vida contributed to the items used on myDNA.live, customers will have access to a higher choice of high quality items.”.

About Heritage Cannabis Holdings Corp.

Heritage is a cannabinoid business concentrated on the production and sale of medical and leisure hemp– based and cannabis– based services and products. In Canada, Heritage runs through its subsidiaries Trip Cannabis Corp. and CannaCure Corp., both managed under the Cannabis Act Laws. Working under these subsidiaries and the Purefarma, Pura Vida and Premium 5 brand names, Heritage concentrates on extraction and the development of acquired items for leisure customers, along with the formula of cannabis based medical options. In the U.S., Heritage runs under Opticann Inc., a Colorado based oral and topical cannabinoid business with the rights to specifically offer CBD and CBG items made with the trademarked VESIsorb ® drug shipment system for enhanced absorption and stability. As the moms and dad business, Heritage is concentrated on supplying the resources for its subsidiaries to advance their product and services to complete both locally and globally.

About Endocanna Health &#x 2122;, Inc.

Endocanna is a biotechnology research study business that uses a patent-pending procedure for its cannabinoid DNA version report, EndoDecoded &#x 2122; and item matching algorithm, EndoAligned &#x 2122;. EndoDNA &#x 2122; supplies 2 methods to send DNA for analysis, either gathered through an easy saliva swab or a direct upload of hereditary information files from popular DNA screening services like Origins, 23andMe, Household TreeDNA, or MyHeritageDNA. Endocanna’s HIPAA certified and safe health and health website, Mydna.live, supplies clients with an individualized experience where they can access their Endo · Translated report and Endo · Aligned formula ideas for their particular genotype. In 2019, cannabis manufacturer Heritage Cannabis Holdings (CSE: CANN; OTC: HERTF) obtained a 30 percent stake in Endocanna Health Inc.

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.

” Clint Sharples”

Clint Sharples

CEO.

The Canadian Securities Exchange does decline obligation for the adequacy or precision of this release.

Latest posts